India-based wellness startup Biopeak, headquartered in Karnataka, has raised $3.5 million in seed funding from prominent investors including Accel, Claypond Capital, and NKSquared. The funds will be used to expand its clinic footprint and enhance its AI-driven diagnostics platform tailored to preventive and longevity care.
India-based wellness and longevity startup Biopeak, headquartered in Bengaluru, Karnataka, has raised $3.5 million in seed funding from top investors, including Claypond Capital (the family office of Manipal Group Chairman Ranjan Pai), Accel founding partner Prashanth Prakash, and NKSquared, the investment vehicle of Zerodha co-founder Nikhil Kamath.
Founded in 2024 by Rishi Pardal and Shiva Subramanian, Biopeak delivers personalised health and longevity services via its in-house clinics. The company blends molecular diagnostics, high-resolution imaging, and non-invasive testing to detect early physiological changes—allowing for better preventive care and chronic condition management.
The company opened its first clinic in Bengaluru in March 2025 and plans to scale operations across India using the newly raised funds. The capital will also enhance its proprietary AI-based diagnostic platform, which supports both wellness optimization and disease prevention.
Speaking on the funding, co-founder and CEO said,
We’re building a data-driven model to help people live longer, healthier lives by intervening before diseases take root.”
Rishi Pardal, Co-founder and CEO of Biopeak
Biopeak serves two primary user groups: individuals seeking peak performance and preventive health and those managing complex or chronic conditions where traditional care models fall short.
The startup is also collaborating with the Indian Institute of Science (IISc) and Longevity India to contextualize its medical models to South Asian demographics and health conditions.
Accel’s Prashanth Prakash, who also mentors Biopeak and is a founding patron of Longevity India, remarked,
India’s ageing population demands healthcare systems that prioritize strength, clarity, and purpose in extended lifespans. Biopeak is pioneering that future.”
With aging, lifestyle diseases, and stress-related health issues on the rise in India, Biopeak’s growth represents a shift in how healthcare can evolve—from reactive treatment to precision-based prevention.
